178 related articles for article (PubMed ID: 32692176)
1. Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
Korkmaz B; Lesner A; Marchand-Adam S; Moss C; Jenne DE
J Med Chem; 2020 Nov; 63(22):13258-13265. PubMed ID: 32692176
[TBL] [Abstract][Full Text] [Related]
2. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
Korkmaz B; Caughey GH; Chapple I; Gauthier F; Hirschfeld J; Jenne DE; Kettritz R; Lalmanach G; Lamort AS; Lauritzen C; Łȩgowska M; Lesner A; Marchand-Adam S; McKaig SJ; Moss C; Pedersen J; Roberts H; Schreiber A; Seren S; Thakker NS
Pharmacol Ther; 2018 Oct; 190():202-236. PubMed ID: 29842917
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin C inhibition as a potential treatment strategy in cancer.
Korkmaz B; Lamort AS; Domain R; Beauvillain C; Gieldon A; Yildirim AÖ; Stathopoulos GT; Rhimi M; Jenne DE; Kettritz R
Biochem Pharmacol; 2021 Dec; 194():114803. PubMed ID: 34678221
[TBL] [Abstract][Full Text] [Related]
5. BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.
Kreideweiss S; Schänzle G; Schnapp G; Vintonyak V; Grundl MA
Inflamm Res; 2023 Aug; 72(8):1709-1717. PubMed ID: 37542002
[TBL] [Abstract][Full Text] [Related]
6. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.
Seren S; Rashed Abouzaid M; Eulenberg-Gustavus C; Hirschfeld J; Nasr Soliman H; Jerke U; N'Guessan K; Dallet-Choisy S; Lesner A; Lauritzen C; Schacher B; Eickholz P; Nagy N; Szell M; Croix C; Viaud-Massuard MC; Al Farraj Aldosari A; Ragunatha S; Ibrahim Mostafa M; Giampieri F; Battino M; Cornillier H; Lorette G; Stephan JL; Goizet C; Pedersen J; Gauthier F; Jenne DE; Marchand-Adam S; Chapple IL; Kettritz R; Korkmaz B
J Biol Chem; 2018 Aug; 293(32):12415-12428. PubMed ID: 29925593
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin C role in inflammatory gastroenterological, renal, rheumatic, and pulmonary disorders.
Aghdassi AA; Pham C; Zierke L; Mariaule V; Korkmaz B; Rhimi M
Biochimie; 2024 Jan; 216():175-180. PubMed ID: 37758158
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases.
Hamon Y; Legowska M; Hervé V; Dallet-Choisy S; Marchand-Adam S; Vanderlynden L; Demonte M; Williams R; Scott CJ; Si-Tahar M; Heuzé-Vourc'h N; Lalmanach G; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2016 Apr; 291(16):8486-99. PubMed ID: 26884336
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.
Shen XB; Chen X; Zhang ZY; Wu FF; Liu XH
Eur J Med Chem; 2021 Dec; 225():113818. PubMed ID: 34492551
[TBL] [Abstract][Full Text] [Related]
10. α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?
Hogan G; Geoghegan P; Carroll TP; Clarke J; McElvaney OF; McElvaney OJ; McElvaney NG; Curley GF
Anesthesiology; 2021 May; 134(5):792-808. PubMed ID: 33721888
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C.
Korkmaz B; Lesner A; Wysocka M; Gieldon A; Håkansson M; Gauthier F; Logan DT; Jenne DE; Lauritzen C; Pedersen J
Biochem Pharmacol; 2019 Jun; 164():349-367. PubMed ID: 30978322
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cathepsin C in PR3-ANCA Vasculitis.
Jerke U; Eulenberg-Gustavus C; Rousselle A; Nicklin P; Kreideweiss S; Grundl MA; Eickholz P; Nickles K; Schreiber A; Korkmaz B; Kettritz R
J Am Soc Nephrol; 2022 May; 33(5):936-947. PubMed ID: 35292437
[TBL] [Abstract][Full Text] [Related]
13. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans.
Pham CT; Ivanovich JL; Raptis SZ; Zehnbauer B; Ley TJ
J Immunol; 2004 Dec; 173(12):7277-81. PubMed ID: 15585850
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
15. Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation.
Rehm SRT; Smirnova NF; Morrone C; Götzfried J; Feuchtinger A; Pedersen J; Korkmaz B; Yildirim AÖ; Jenne DE
Sci Rep; 2019 Jul; 9(1):9925. PubMed ID: 31289357
[TBL] [Abstract][Full Text] [Related]
16. Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors.
Hou W; Sun H; Ma Y; Liu C; Zhang Z
J Med Chem; 2019 Jun; 62(12):5901-5919. PubMed ID: 31145622
[TBL] [Abstract][Full Text] [Related]
17. Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy.
Banerjee A; Velagaleti R; Patil S; Pawar M; Yadav P; Kadam P; Qadri MM; Chakraborti S; Saini JS; Behera DB; Karanjai K; Iyer PS; Gharat LA; Das S
Bioorg Med Chem Lett; 2021 Sep; 47():128202. PubMed ID: 34139325
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic utility and medicinal chemistry of cathepsin C inhibitors.
Guay D; Beaulieu C; Percival MD
Curr Top Med Chem; 2010; 10(7):708-16. PubMed ID: 20337582
[TBL] [Abstract][Full Text] [Related]
19. An elastase activity reporter for Electronic Paramagnetic Resonance (EPR) and Overhauser-enhanced Magnetic Resonance Imaging (OMRI) as a line-shifting nitroxide.
Jugniot N; Duttagupta I; Rivot A; Massot P; Cardiet C; Pizzoccaro A; Jean M; Vanthuyne N; Franconi JM; Voisin P; Devouassoux G; Parzy E; Thiaudiere E; Marque SRA; Bentaher A; Audran G; Mellet P
Free Radic Biol Med; 2018 Oct; 126():101-112. PubMed ID: 30092349
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats.
Liu B; Korkmaz B; Kraft P; Mayer T; Sayour AA; Grundl MA; Domain R; Karck M; Szabó G; Korkmaz-Icöz S
J Transl Med; 2023 Nov; 21(1):799. PubMed ID: 37946197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
